Angiotensins

Diabetic Beneficiaries Receive Extra Push to Stay Healthy

Published in Managed Care Weekly Digest, June 18th, 2007

For many people with diabetes, kidney damage and cardiovascular complications are devastating side effects of the disease. Fortunately, two classes of medications - ACEI (Angiotensin Converting Enzyme Inhibitors) or ARB (Angiotensin Receptor Blockers) - have been proven to help reduce the progression of kidney and cardiovascular problems.

To help keep its diabetic beneficiaries healthy, MemberHealth's CCRx Medicare Part D Prescription Drug Plan recently started working with physicians to ensure they prescribe ACEIs or ARBs for beneficiaries with diabetes. As a result, 68 percent of CCRx's beneficiaries with diabetes are now taking an ACEI or ARB.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Managed Care Weekly Digest

Source: Managed Care Weekly Digest (2007-06-18)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry